Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 34821-34830 Newer>

The Motley Fool February 23, 2009 Tim Beyers	Stocks to Avoid Now? Sometimes insiders are selling for all the right reasons.
The Motley Fool February 23, 2009 Christopher Barker	Rogue Wave Swamps Dry Bulk Shippers Now that a series of dramatic developments have bashed the dry bulk shippers like a rogue wave, and fourth-quarter results are beginning to emerge, let's step back and take a comprehensive look at the sector.
The Motley Fool February 23, 2009 Brian Orelli	Genzyme Playing Defense The latest good news from this company won't help the top line much.
The Motley Fool February 23, 2009 Tim Beyers	Why Google Shouldn't Pay a Dividend Or not an ongoing one, at least.
The Motley Fool February 23, 2009 Anders Bylund	Great Is Still Better Than Good Bestselling business book author Jim Collins and his "great" companies still look really smart, compared to the rest of the market.
The Motley Fool February 23, 2009 Chris Jones	Dycom: Down But Not Out Dycom relies on spending from telecommunications providers; AT&T and Verizon make up more than a third of Dycom's sales, so when the big guys spend less, it affects Dycom, too.
The Motley Fool February 23, 2009	3 Stocks Hitting Low Notes These stocks have hit bottom. Are they ready to bounce? Take a look at: Owens Corning... Embraer-Empresa Brasileir de Aero... Pioneer Drilling Company...
The Motley Fool February 23, 2009 Brian Orelli	The DOJ v. Johnson & Johnson The U.S. Department of Justice is joining a lawsuit against the health care giant over the company's marketing of heart failure drug Natrecor.
The Motley Fool February 23, 2009 David Lee Smith	Will China Strike Black Gold in Brazil? China and Petrobras might be about to combine in a way that would benefit both.
The Motley Fool February 23, 2009 Brian Orelli	Why Do You Hate Health-Care Companies So Much? Members of Congress plan to introduce a bill that would give patients legal recourse against medical device companies making drug-eluting stents, essentially nullifying a previous Supreme Court decision.
<Older 34821-34830 Newer> Return to current articles.